Published in Am J Surg on January 01, 1995
Extent of small bowel resection does not influence the magnitude of intestinal adaptation in the mouse. J Pediatr Surg (2010) 0.87
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut (2010) 3.67
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology (1992) 2.57
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek (1999) 2.14
Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology (1996) 2.14
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol (1982) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci (1995) 1.58
Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet (1995) 1.57
Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology (1998) 1.52
Endoscopic transmission of hepatitis B virus. Gut (1983) 1.50
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet (1999) 1.48
Gastrointestinal symptoms in Parkinson's disease. Mov Disord (1991) 1.44
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology (1984) 1.42
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
Inflammatory polyps as a manifestation of intestinal graft versus host disease. Gastrointest Endosc (1993) 1.40
Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology (1988) 1.40
pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients. Gastroenterology (1987) 1.39
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol (1996) 1.34
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas (2000) 1.33
Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology (1986) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther (2012) 1.24
Regulatory peptides in the mammalian respiratory tract. Endocrinology (1982) 1.21
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand (1981) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Gut hormone release after intestinal resection. Gut (1982) 1.18
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg (1995) 1.17
Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol (1997) 1.17
Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE). Am J Gastroenterol (2000) 1.17
Peptidergic innervation of the human male genital tract. J Urol (1983) 1.16
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut (1985) 1.15
Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endocrinology (1991) 1.15
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology (1983) 1.14
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut (1985) 1.14
Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion (1984) 1.13
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun (1999) 1.12
Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care (1998) 1.12
Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther (1998) 1.11
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
Superior mesenteric artery thrombosis after colonoscopy. Gastrointest Endosc (1999) 1.11
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia (1978) 1.10
On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol (2004) 1.10
Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther (2011) 1.10
Somatostatin and the dumping syndrome. Br Med J (Clin Res Ed) (1985) 1.10
Symptoms and gastric function in dyspepsia--goodbye to gastroparesis? Neurogastroenterol Motil (1996) 1.08
Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry (1984) 1.07
Motility of the ileocolonic junction. Gut (1988) 1.06
Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas (1997) 1.06
Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Ann N Y Acad Sci (2008) 1.06
Pancreatic tumours produce neurotensin. J Clin Endocrinol Metab (1981) 1.05
Colorectal cancer screening compliance by medicine residents: perceived and actual. Am J Gastroenterol (2001) 1.05
Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res (2000) 1.05
Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol (1994) 1.05
In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J Surg Res (1998) 1.04
Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. J Physiol (1983) 1.04
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. Dig Dis Sci (1993) 1.04
Pharmacological management of constipation. Neurogastroenterol Motil (2009) 1.04
Peptic ulcer and cancer: an examination of the relationship between chronic peptic ulcer and gastric carcinoma. Scand J Gastroenterol (1987) 1.03
Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil (2014) 1.03
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br J Cancer (2008) 1.03
Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology (2001) 1.02
The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals. J Comp Neurol (1984) 1.02
Chylous ascites, intestinal lymphangiectasia and the 'yellow-nail' syndrome. Gut (1985) 1.02
Effect of meal composition and sham feeding on duodenojejunal motility in humans. Dig Dis Sci (1992) 1.02
Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg (1996) 1.01
The ileocecal (ileocolonic) sphincter. Z Gastroenterol (1983) 1.01
Effects of morphine and atropine on motility and transit in the human ileum. Gastroenterology (1985) 1.01
Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med (1982) 1.01
Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology (1983) 1.01
The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin Endocrinol Metab (2000) 1.00
Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man. Eur J Clin Invest (1979) 1.00
Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1983) 1.00
The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man. Clin Sci (Lond) (1983) 1.00
Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery (1987) 0.99
Transdifferentiation of human islet cells in a long-term culture. Pancreas (2001) 0.99
Principles of applied neurogastroenterology: physiology/motility-sensation. Gut (1999) 0.99
Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology (1980) 0.99
Distinctive patterns of interdigestive motility at the canine ileocolonic junction. Gastroenterology (1984) 0.98